Inside the 2025 ASC Market: Valuations, Hot Specialties & What’s Next
The ambulatory surgery center (ASC) market is facing a period of recalibration in 2025. A confluence of macroeconomic pressures, shifting specialty performance and evolving investment strategies has shaped the pace and structure of dealmaking across the sector. While demand for outpatient care remains strong, M&A activity has cooled, at least on the surface. To explore these trends, we interviewed Colin Park, Managing Director at VMG Health, a leading healthcare valuation and transaction advisory firm serving both buy-side and sell-side clients. Park’s insights reveal the forces currently shaping ASC M&A, the most resilient ASC specialties, how regulatory and cost pressures... Read More »
Ascension Acquires AmSurg in Major Push Into Outpatient Care
On June 17, Ascension announced that it had entered into an agreement to acquire AmSurg Corp, marking one of the largest pushes into the outpatient care market by a health system. AmSurg, through its subsidiaries, provides ambulatory and physician services in the United States. It operates 257 ambulatory surgery centers (ASC) in 34 states and provides physician services to 450 healthcare facilities in 29 states. The centers specialize in gastroenterology, ophthalmology, orthopedics and other services. Ascension is the largest nonprofit health system in the United States. Its healthcare division operates 151 hospitals and more than 50 senior living facilities. In Florida, it operates... Read More »
A Conversation with Siemens at BOMA
The BOMA Conference in Denver, Colorado, brought together medical real estate industry leaders for three days filled with insightful conversations and engaging panels. Overall, the tone was cautiously optimistic, with many industry experts anticipating that medical real estate deal volume will pick up in the second half of the year. Several themes circulated throughout the conference across the panels and attendees: the slower M&A market in the first half of 2025, the rise of new construction and the state of the lending market. Why has M&A volume dropped? The LevinPro HC team spoke with Edward Finkenstaedt, Senior Risk Manager and Team Leader of Siemens Financial Services, who... Read More »
Private Equity Firm HCAP Partners Acquires First Choice Mobile Radiology Services
HCAP Partners has acquired First Choice Mobile Radiology Services (FCMR) as the first acquisition under its new mobile imaging platform, Integrated Diagnostic Services (IDS). This strategic transaction represents a significant development in the mobile diagnostic imaging sector, which has seen considerable activity in 2024-2025. The acquisition aligns with broader healthcare trends showing a shift toward outpatient and mobile diagnostic settings. The acquisition was announced on April 22, 2025. This acquisition is part of HCAP’s strategy to expand access to mobile diagnostics for senior care and home health populations through its IDS platform. IDS aims to build a regional platform... Read More »
Revelstoke Capital Partners Recapitalizes AOM Infusion: Strategic Investment in High-Growth Specialty Infusion Market
Revelstoke Capital Partners announced in April 2025 a recapitalization of AOM Infusion, with the transaction having closed on March 19, 2025. This investment marks the ninth from Revelstoke Capital Partners Fund III. Ridgemont Equity Partners, which previously owned AOM Infusion, will retain a minority equity position following this recapitalization. Financial terms of the deal were not disclosed. This report analyzes the transaction in the context of the rapidly growing specialty infusion market, which is experiencing significant private equity interest due to the shift toward home and ambulatory care settings, an aging population and expanding pipeline of infusible therapies. About AOM... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
